Antimicrobial activity of ear cleanser products against biofilm and planktonic phases of Staphylococcus spp. and Pseudomonas spp. isolated from canine skin and ear infections

Abstract Background Staphylococcus spp., and Pseudomonas spp., including multidrug resistant staphylococci are frequent isolates from canine otitis externa and atopic dermatitis. The ability of these bacteria to form biofilms significantly contributes to the chronic nature of otitis. To manage micro...

Full description

Saved in:
Bibliographic Details
Main Authors: Abish S. Stephen, Vanessa Chala, Céline S. Nicolas, Pierre Jasmin, Robert P. Allaker
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Veterinary Research
Subjects:
Online Access:https://doi.org/10.1186/s12917-025-04526-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761571369123840
author Abish S. Stephen
Vanessa Chala
Céline S. Nicolas
Pierre Jasmin
Robert P. Allaker
author_facet Abish S. Stephen
Vanessa Chala
Céline S. Nicolas
Pierre Jasmin
Robert P. Allaker
author_sort Abish S. Stephen
collection DOAJ
description Abstract Background Staphylococcus spp., and Pseudomonas spp., including multidrug resistant staphylococci are frequent isolates from canine otitis externa and atopic dermatitis. The ability of these bacteria to form biofilms significantly contributes to the chronic nature of otitis. To manage microbial overgrowth, ear cleanser products are commonly used. It is important therefore, to measure their antibiofilm effects. In this study, six ear cleansers (EpioticⓇ SIS, EpioticⓇ Advanced, CleanauralⓇ, OtifreeⓇ, PeptivetⓇ and SonotixⓇ) were evaluated against clinical isolates of Pseudomonas aeruginosa, methicillin resistant and sensitive Staphylococcus aureus and Staphylococcus pseudintermedius. Antibiofilm activity was measured using a colorimetric assay that detects viable cells through the reduction of thiazolyl blue tetrazolium bromide (MTT). Additionally, minimum inhibitory concentration (MIC) of Epiotic SIS and Epiotic Advanced were determined using a broth micro-dilution assay to assess their ability to inhibit bacteria in the planktonic state. Results Epiotic (SIS and Advanced), Cleanaural and Peptivet showed high antibiofilm activity, with Otifree and Sonotix showing moderate to low antibiofilm activity. Notably, Otifree was significantly less effective at inhibiting methicillin-resistant S. aureus compared to methicillin-sensitive strains. P. aeruginosa biofilms were less effectively disrupted by some ear cleansers, and the MIC results indicated that less diluted solutions were required to inhibit this isolate compared to the staphylococcal species. Differences in the antibacterial effects between Epiotic SIS and Epiotic Advanced solutions could also be detected from the MIC assays suggesting differences in formulations can affect antimicrobial efficacy. Conclusions Commonly used canine ear cleanser products showed variable activity against multidrug resistant and sensitive Staphylococcus spp. and P. aeruginosa isolates in both biofilm and planktonic phases. The observed differences between bacterial strains and cleanser formulations highlight the importance of selecting appropriate products for targeted microbial control, which can lead to more effective management of chronic otitis externa and atopic dermatitis in dogs.
format Article
id doaj-art-e58a4bdc20954ef2890ca6b7ff2a08e7
institution DOAJ
issn 1746-6148
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series BMC Veterinary Research
spelling doaj-art-e58a4bdc20954ef2890ca6b7ff2a08e72025-08-20T03:06:00ZengBMCBMC Veterinary Research1746-61482025-03-012111810.1186/s12917-025-04526-0Antimicrobial activity of ear cleanser products against biofilm and planktonic phases of Staphylococcus spp. and Pseudomonas spp. isolated from canine skin and ear infectionsAbish S. Stephen0Vanessa Chala1Céline S. Nicolas2Pierre Jasmin3Robert P. Allaker4Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Queen Mary University of LondonGlobal MarketingGlobal MarketingGlobal MarketingCentre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Queen Mary University of LondonAbstract Background Staphylococcus spp., and Pseudomonas spp., including multidrug resistant staphylococci are frequent isolates from canine otitis externa and atopic dermatitis. The ability of these bacteria to form biofilms significantly contributes to the chronic nature of otitis. To manage microbial overgrowth, ear cleanser products are commonly used. It is important therefore, to measure their antibiofilm effects. In this study, six ear cleansers (EpioticⓇ SIS, EpioticⓇ Advanced, CleanauralⓇ, OtifreeⓇ, PeptivetⓇ and SonotixⓇ) were evaluated against clinical isolates of Pseudomonas aeruginosa, methicillin resistant and sensitive Staphylococcus aureus and Staphylococcus pseudintermedius. Antibiofilm activity was measured using a colorimetric assay that detects viable cells through the reduction of thiazolyl blue tetrazolium bromide (MTT). Additionally, minimum inhibitory concentration (MIC) of Epiotic SIS and Epiotic Advanced were determined using a broth micro-dilution assay to assess their ability to inhibit bacteria in the planktonic state. Results Epiotic (SIS and Advanced), Cleanaural and Peptivet showed high antibiofilm activity, with Otifree and Sonotix showing moderate to low antibiofilm activity. Notably, Otifree was significantly less effective at inhibiting methicillin-resistant S. aureus compared to methicillin-sensitive strains. P. aeruginosa biofilms were less effectively disrupted by some ear cleansers, and the MIC results indicated that less diluted solutions were required to inhibit this isolate compared to the staphylococcal species. Differences in the antibacterial effects between Epiotic SIS and Epiotic Advanced solutions could also be detected from the MIC assays suggesting differences in formulations can affect antimicrobial efficacy. Conclusions Commonly used canine ear cleanser products showed variable activity against multidrug resistant and sensitive Staphylococcus spp. and P. aeruginosa isolates in both biofilm and planktonic phases. The observed differences between bacterial strains and cleanser formulations highlight the importance of selecting appropriate products for targeted microbial control, which can lead to more effective management of chronic otitis externa and atopic dermatitis in dogs.https://doi.org/10.1186/s12917-025-04526-0CanineOtitisBiofilmAntimicrobialCleanserMRSA
spellingShingle Abish S. Stephen
Vanessa Chala
Céline S. Nicolas
Pierre Jasmin
Robert P. Allaker
Antimicrobial activity of ear cleanser products against biofilm and planktonic phases of Staphylococcus spp. and Pseudomonas spp. isolated from canine skin and ear infections
BMC Veterinary Research
Canine
Otitis
Biofilm
Antimicrobial
Cleanser
MRSA
title Antimicrobial activity of ear cleanser products against biofilm and planktonic phases of Staphylococcus spp. and Pseudomonas spp. isolated from canine skin and ear infections
title_full Antimicrobial activity of ear cleanser products against biofilm and planktonic phases of Staphylococcus spp. and Pseudomonas spp. isolated from canine skin and ear infections
title_fullStr Antimicrobial activity of ear cleanser products against biofilm and planktonic phases of Staphylococcus spp. and Pseudomonas spp. isolated from canine skin and ear infections
title_full_unstemmed Antimicrobial activity of ear cleanser products against biofilm and planktonic phases of Staphylococcus spp. and Pseudomonas spp. isolated from canine skin and ear infections
title_short Antimicrobial activity of ear cleanser products against biofilm and planktonic phases of Staphylococcus spp. and Pseudomonas spp. isolated from canine skin and ear infections
title_sort antimicrobial activity of ear cleanser products against biofilm and planktonic phases of staphylococcus spp and pseudomonas spp isolated from canine skin and ear infections
topic Canine
Otitis
Biofilm
Antimicrobial
Cleanser
MRSA
url https://doi.org/10.1186/s12917-025-04526-0
work_keys_str_mv AT abishsstephen antimicrobialactivityofearcleanserproductsagainstbiofilmandplanktonicphasesofstaphylococcussppandpseudomonassppisolatedfromcanineskinandearinfections
AT vanessachala antimicrobialactivityofearcleanserproductsagainstbiofilmandplanktonicphasesofstaphylococcussppandpseudomonassppisolatedfromcanineskinandearinfections
AT celinesnicolas antimicrobialactivityofearcleanserproductsagainstbiofilmandplanktonicphasesofstaphylococcussppandpseudomonassppisolatedfromcanineskinandearinfections
AT pierrejasmin antimicrobialactivityofearcleanserproductsagainstbiofilmandplanktonicphasesofstaphylococcussppandpseudomonassppisolatedfromcanineskinandearinfections
AT robertpallaker antimicrobialactivityofearcleanserproductsagainstbiofilmandplanktonicphasesofstaphylococcussppandpseudomonassppisolatedfromcanineskinandearinfections